Cargando…
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
Introduction: serum alpha-fetoprotein (AFP) was routinely employed as a tumor marker for screening, diagnosis, and treatment follow-up of hepatocellular carcinoma (HCC). However, a substantial proportion of HCC patients had normal AFP level even at an advanced disease status. Few studies to date had...
Autores principales: | Lee, Chao-Wei, Tsai, Hsin-I, Lee, Wei-Chen, Huang, Shu-Wei, Lin, Cheng-Yu, Hsieh, Yi-Chung, Kuo, Tony, Chen, Chun-Wei, Yu, Ming-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832124/ https://www.ncbi.nlm.nih.gov/pubmed/31635078 http://dx.doi.org/10.3390/jcm8101736 |
Ejemplares similares
-
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study
por: Lee, Chao-Wei, et al.
Publicado: (2020) -
Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019) -
Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein
por: Jin, Young-Joo, et al.
Publicado: (2020) -
Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
por: Yen, Yi-Hao, et al.
Publicado: (2023) -
The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
por: Hu, Xin, et al.
Publicado: (2022)